Endometriosis and nuclear receptors
Open accessThe DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index; 46 of the 107 sources its claims cite were checked for support.
Abstract
BACKGROUND: Endometriosis is recognized as a steroid-dependent disorder; however, the precise roles of nuclear receptors (NRs) in steroid responsiveness and other signaling pathways are not well understood. OBJECTIVE AND RATIONALE: Over the past several years, a number of paradigm-shifting breakthroughs have occurred in the area of NRs in endometriosis. We review and clarify new information regarding the mechanisms responsible for: (i) excessive estrogen biosynthesis, (ii) estrogen-dependent inflammation, (iii) defective differentiation due to progesterone resistance and (iv) enhanced survival due to deficient retinoid production and action in endometriosis. We emphasize the roles of the relevant NRs critical for these pathological processes in endometriosis. SEARCH METHODS: We conducted a comprehensive search using PubMed for human, animal and cellular studies published until 2018 in the following areas: endometriosis; the steroid and orphan NRs, estrogen receptors alpha (ESR1) and beta (ESR2), progesterone receptor (PGR), steroidogenic factor-1 (NR5A1) and chicken ovalbumin upstream promoter-transcription factor II (NR2F2); and retinoids. OUTCOMES: Four distinct abnormalities in the intracavitary endometrium and extra-uterine endometriotic tissue underlie endometriosis progression: dysregulated differentiation of endometrial mesenchymal cells, abnormal epigenetic marks, inflammation activated by excess estrogen and the development of progesterone resistance. Endometriotic stromal cells compose the bulk of the lesions and demonstrate widespread epigenetic abnormalities. Endometriotic stromal cells also display a wide range of abnormal NR expression. The orphan NRs NR5A1 and NR2F2 compete to regulate steroid-synthesizing genes in endometriotic stromal cells; NR5A1 dominance gives rise to excessive estrogen formation. Endometriotic stromal cells show an abnormally low ESR1:ESR2 ratio due to excessive levels of ESR2, which mediates an estrogen-driven inflammatory process and prostaglandin formation. These cells are also deficient in PGR, leading to progesterone resistance and defective retinoid synthesis. The pattern of NR expression, involving low ESR1 and PGR and high ESR2, is reminiscent of uterine leiomyoma stem cells. This led us to speculate that endometriotic stromal cells may display stem cell characteristics found in other uterine tissues. The biologic consequences of these abnormalities in endometriotic tissue include intense inflammation, defective differentiation and enhanced survival. WIDER IMPLICATIONS: Steroid- and other NR-related abnormalities exert genome-wide biologic effects via interaction with defective epigenetic programming and enhance inflammation in endometriotic stromal cells. New synthetic ligands, targeting PGR, retinoic acid receptors and ESR2, may offer novel treatment options.
Overview
CoChat Summary
TL;DR
This review synthesizes evidence that nuclear receptors—especially NR5A1, NR2F2, ESR1/ESR2, PGR, and retinoid receptors—drive endometriosis through excessive local estrogen synthesis, estrogen-dependent inflammation, progesterone resistance, and deficient retinoid action. It highlights epigenetic abnormalities in endometriotic stromal cells and stem-cell-like populations as central mechanisms and discusses emerging receptor-targeted therapies.
Key findings
- NR5A1 mRNA is ~12,000-fold higher in endometriosis than in eutopic endometrium; NR5A1 binds promoters of StAR, CYP11A1, HSD3B2, CYP17A1, and aromatase, and competes with NR2F2 to activate steroidogenic genes in endometriotic stromal cells.
- ESR2 RNA is 40- to 140-fold higher in stromal cells from ovarian endometriomas than in healthy eutopic endometrial stromal cells; the ESR2:ESR1 mRNA ratio reaches an ~800-fold difference, while ESR1 mRNA is ~7-fold lower.
- Progesterone resistance involves very low PGR-A and undetectable PGR-B in peritoneal endometriotic lesions, with PGR-B promoter hypermethylation and microRNA-mediated PGR downregulation (e.g., miR-194-3p, miR-196a, miR-29c).
- Retinoid deficiency in endometriotic stromal cells includes downregulated STRA6, deficient RBP1, higher CYP26B1, and a decreased CRABP2:FABP5 ratio, favoring FABP5/PPAR-β/δ-mediated survival and reduced HSD17B2-dependent estradiol inactivation.
Methods
- Comprehensive PubMed search for English-language human, animal, and cellular studies published until June 2018, using keywords including endometriosis, ESR1, ESR2, PGR, NR5A1, NR2F2, RAR, and endometrial stem cells.
- Narrative review and synthesis of the literature on nuclear receptors in endometriosis pathogenesis, progression, and therapeutic targeting; no formal meta-analysis or quantitative pooling is described.
Limitations
- The paper states that no germ-line or causative somatic mutations have been reported in endometriosis, that the relationship between DNMT expression and ESR2 promoter hypomethylation remains to be discovered, that long-term efficacy of SPRMs remains to be proven, and that future preclinical studies are required for ESR2-targeting agents.
- Evident from the text: this is a narrative review with a PubMed search limited to June 2018, relying heavily on animal and cell-culture models; it reports inconsistent polymorphism associations and does not perform a systematic risk-of-bias assessment or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
37 Valid · 3 Not valid · 40 Not checked · 31 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“NR5A1 serves as a key downstream mediator of prostaglandin E 2 (PGE 2 ) action”
What the sources say
- Disputedcites Sirianni et al., 2009 sourceExperimental — accuracy not yet measured
The paper distinguishes SF-1 (NR5A1) from the PGE2-mediated pathway. Its introductory text attributes increased SF-1 transcription to insulin-like growth factor I signaling, while the Abstract identifies EP4, PKA and CREB—not SF-1—as mediators of PGE2 action. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“It was shown that cytokines such as colony-stimulating factor-1 secreted from macrophages increase the proliferation and invasion activity of endometriotic stem cells (Chan et al., 2017).”
What the sources say
- Disputedcites Chan et al., 2017 sourceExperimental — accuracy not yet measured
The Results report that macrophage co-culture increased the clonogenicity and invasion of endometriotic stromal cells. But the Discussion explicitly says CSF-1 alone did not affect either activity; the factors responsible for the co-culture effect were not determined. The cited paper therefore does not support attributing the increase to macrophage-secreted CSF-1. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When injected into subcutaneous tissue or the kidney capsule of NOD-SCID mouse, side population cells regenerate human endometrial stroma, glandular epithelium and endothelium (Cervello et al., 2010(Cervello et al., , 2011;;Miyazaki et al., 2012).”
What the sources say
- Partly supportedcites Cervello et al., 2010 sourceExperimental — accuracy not yet measured
The Results section (‘Reconstruction of human endometrial-like tissue from SP in NOD-SCID mice’; page unavailable) reports endometrial-like glands and stroma after subcutaneous injection of stromal side-population cells, but only in one animal. The Methods describe subcutaneous injection, not injection under the kidney capsule. The observed structure was vascularized, but the paper does not establish regeneration of human endothelium. (LLM, conf=0.88)
- Disputedcites Cervello et al., 2011 sourceExperimental — accuracy not yet measured
The Results section (page unavailable) supports reconstruction of human endometrial tissue beneath the kidney capsule, with human stromal and epithelial markers. But it explicitly reports that the human endothelial marker hCD31 was not detected and suggests the new blood vessels came from the mouse host, contrary to the claim that the cells regenerated human endothelium. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites Miyazaki et al., 2012 sourceExperimental — accuracy not yet measured
The Results (Histological and Immunohistochemical Analysis; page unavailable) report that endometrial side population cells contributed to reconstituted stromal, epithelial and endothelial lineages. But the Methods (Xenotransplantation and Hormonal Treatment; page unavailable) place the cells under the kidney capsule of NOG mice, not in subcutaneous tissue; the subcutaneous implants were hormone pellets. The assay also mixed the side population cells with other endometrial cells. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the endometriotic stromal cells, NR5A1 is essential for supporting high levels of proteins and enzymes that drive the serial conversion of cholesterol to estradiol”
What the sources say
- Partly supportedcites Attar et al., 2009 sourceExperimental — accuracy not yet measured
The Discussion (page not available) says endometriotic stromal cells contain the full enzymatic cascade for producing estradiol from cholesterol and identifies the PGE2–SF1 pathway as a key regulator. The gene-expression results also show high SF1 and steroidogenic-gene mRNA levels in endometriotic tissue. The paper does not establish that SF1 is essential for maintaining those levels; it describes SF1 as a possible key regulator and shows that its overexpression activates a promoter. (LLM, conf=0.83)
- Not matchedcites Bernardi et al., 2018
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“RNA expression of ESR2 is 40-to 140-fold higher in stromal cells obtained from ovarian endometriomas compared to healthy eutopic endometrial stromal cells”
What the sources say
- Not checked — no full text of the sourcecites Smuc et al., 2007 source
- Not matchedcites Xue et al., 2007a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Yang et al., 2015 sourceExperimental — accuracy not yet measured
The Discussion reports that ESR2 expression was upregulated in endometriosis samples. It does not report a 40- to 140-fold increase or establish that comparison specifically for stromal cells from ovarian endometriomas versus healthy eutopic endometrial stromal cells. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims · 18 with their cited sources checked
Create a free account to see all 111 claims and every source verdict.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 18
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In endometrial stromal cells, progesterone increases formation of RA, which triggers expression of 17β-HSD2 in epithelial cells.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“As estrogens play a crucial role not only in survival of endometriotic implants, but also in coordinated vasculogenesis and neurogenesis [110] by different pathways involving ER signaling [15,16], it is logical to consider lowering estrogen levels as a therapeutic approach.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Retinoic acid signaling and function in the endometrium
“peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ)”
§ Discussion
“PPARβ/δ, peroxisome proliferator-activated receptors beta/gamma;”
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., & Julius, D. (2000) · Science · doi:10.1126/science.288.5464.306 · Cited by 3,544
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationLuo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631 · cited 2×
“NR5A1 plays a critical role in regulating steroidogenic pathways in the adrenal gland, testis and ovary (Luo et al., 1994; Hanley et al., 2000).”
BackgroundKastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
“In terms of alterations in ERs activity, an overexpression of ERβ and a downregulation of ERα [39, 40] have been observed in endometriosis.”
BackgroundEndometriosis-Associated Macrophages: Origin, Phenotype, and Function
Hogg, C., Horne, A. W., & Greaves, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00007 · Cited by 238
“Estrogen signaling modulates a large number of down-stream disease processes within endometriosis lesions, which are reviewed in Yilmaz and Bulun (30), Liang et al. (31), and Rizner (32).”
BackgroundRegulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis
García-Gómez, E., Vázquez-Martínez, E. R., Reyes-Mayoral, C., Cruz-Orozco, O. P., Camacho-Arroyo, I., & Cerbón, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00935 · Cited by 195
“In contrast, both progesterone receptor isoforms PR-A and PR-B (PRG) show a decreased expression; in particular, PR-B undergoes a drastic downregulation (mRNA and protein levels), which is mainly due to hypermethylation of the PR-B promoter (25), therefore affecting downstream hormone target genes (26).”
BackgroundDonnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Metadata
- Authors
- Yilmaz, B. D., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-27
- Volume
- 25
- Issue
- 4
- Pages
- 473-485
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- PMC
- PMC6601390
- OpenAlex
- W2915590567
- Cited by
- 243
- References
- 191
- Citations by year
- 2026: 26 · 2025: 27 · 2024: 50 · 2023: 42 · 2022: 30 · 2021: 33 · 2020: 27 · 2019: 7
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R37-HD38691)
- Vehbi Koc Foundation
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- endometriosis, nuclear receptors, estrogen receptor, ESR1, ESR2, progesterone receptor, steroidogenic factor 1, NR2F2, retinoids, estrogen synthesis, progesterone resistance, endometrial differentiation, epigenetic abnormalities, endometriotic stromal cells, stem cell properties
- MeSH terms
- Animals, Endometriosis, Estrogens, Female, Hormone Antagonists, Hormones, Humans, Ligands, Progesterone, Signal Transduction, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endometriosis and nuclear receptors. https://app.cochat.ai/papers/10.1093/humupd/dmz005
- The paper
- Yilmaz, B. D., & Bulun, S. E. (2019). Endometriosis and nuclear receptors. Human Reproduction Update. https://doi.org/10.1093/humupd/dmz005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.